Standard_Form_30_P0003.pdf

PDF 2 MB Posted

Attached to
Evaluation of Abuse Potential of Synthetic Opioids Using In Vivo Pharmacological Studies
Solicitation number
15DDHQ19Q00000012
Issued by

About this file

Standard Form 30

View the file

Other files

File Type Posted
Amendment_0004_-_Request_for_Quote_15DDHQ19Q00000012.pdf PDF
Standard_Form_30_(2).pdf PDF
Revised_Statement_of_Work.pdf PDF
VENDOR_QUESTIONS_-_15DDHQ19Q00000012.docx DOCX document
SF-_30.pdf PDF
SF-18.xml XML file
15DDHQ19Q00000012_(1).pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

I. Schedule of Services – Section 1

Unit cost estimates for different pharmacological tests.

Advance payments for costs incurred to conduct assays as specified in Table 1 or 2 are not authorized. Vendor will bill DEA on a monthly basis based on actual expenses (i.e., consumables, assay costs). Expense report will include total number of assays completed and the unit cost of each type of assay (e.g., 4 drug discrimination assays x specified unit cost = $). Drug costs will vary depending on amount needed. Any drug amount exceeding 1 g or a cost of $500 will need approval by DEA prior to ordering.

Table 1. Assay costs for Base Year

Assay Quantity Unit Unit Price ESTIMATED TOTAL

PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost 1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug Assay Cost

1 EA

Drug Discrimination of test drug Incidental Cost

1 EA

Drug Cost - Not to Exceed 1 EA $500 $500

TOTAL COST ($)

Table 1. Assay costs for Option Year I

PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost 1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug Assay Cost

1 EA

Drug Discrimination of test drug Incidental Cost

1 EA

Table 1. Assay costs for Option Year II

PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost 1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug Assay Cost

1 EA

Drug Discrimination of test drug Incidental Cost

1 EA

Table 1. Assay costs for Option Year III

PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost 1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug

1 EA

Incidental Cost

1 EA

Table 1. Assay costs for Option Year IV

PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost 1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug Assay Cost

1 EA

Drug Discrimination of test drug Incidental Cost

1 EA

ATTACHMENT 2: SAMPLE BPA CALL ORDER

The purpose of this BPA Call Order is to provide contractors DEA’s projected annual estimates to be ordered against the BPA.

(FOR PRICING EVALUATION PURPOSES ONLY)

The Sample BPA Call Order will be used for evaluating the contractor’s proposed price for each BPA year. The contractor shall enter its proposed unit price by contract line item number

(CLIN) for the base period and each option period. The contractor shall enter the total price for each period and grand total for all periods combined. The contractor shall complete all calculations and fill in all spaces provided on the form.

Proposals that do not include pricing in the Sample BPA Call Order in its entirety (“all or none basis”) will not be evaluated by the government.

The completed Sample BPA Call Order shall be submitted with the contractor’s Proposal – the evaluation of which shall be considered for award of the resulting single BPA. In addition, the contractor shall enter the proposed, fixed fully loaded rate from the Sample BPA Call Order for the base and option periods in Section 2 of the RFQ. The proposed rates from the Sample BPA Call Order shall be identical to the proposed rates in Section 1. The proposed rates should be a fully loaded rate that includes direct labor, overhead fringe, general administrative and expenses, and profit. Failure to provide pricing for all CLINS in the Sample BPA Call Order and in Section 2 will result in elimination from further consideration.

DO NOT CHANGE EDIT ORD MANIPULATE THE TABLE

Assay costs for Base Year

CLIN

Assay Quantity Unit Unit Price ESTIMATED

TOTAL PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost

1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost

1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug

Incidental Cost

0009 Drug Cost - Not to Exceed 1 EA $500 $500

Assay costs for Option Year I

CLIN

Assay Quantity Unit Unit Price ESTIMATED

TOTAL PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost

1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost

1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug Assay Cost

1 EA

Drug Discrimination of test drug Incidental Cost

1009 Drug Cost - Not to Exceed 1 EA $500 $500

Assay costs for Option Year II

Assay Quantity Unit Unit Price ESTIMATED

TOTAL PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) 1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost

1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug Assay Cost

1 EA

Drug Discrimination of test drug Incidental Cost

2009 Drug Cost - Not to Exceed 1 EA $500 $500

Assay costs for Option Year III

Assay Quantity Unit Unit Price ESTIMATED

TOTAL PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost

1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost

1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug Assay Cost

1 EA

Drug Discrimination of test drug Incidental Cost

3009 Drug Cost - Not to Exceed 1 EA $500 $500

Assay costs for Option Year IV

Assay Quantity Unit Unit Price ESTIMATED

TOTAL PRICE

Locomotor (or other dose-finding assay) Assay Cost 1 EA

Locomotor (or other dose-finding assay) Incidental Cost 1 EA

Analgesia Studies (to include antagonist studies) Assay Cost

1 EA

Analgesia Studies (to include antagonist studies) Incidental Cost

1 EA

Drug Discrimination (monthly maintenance of training drugs) Assay Cost 1 EA

Drug Discrimination (monthly maintenance of training drugs) Incidental Cost 1 EA

Drug Discrimination of test drug Assay Cost

1 EA

Drug Discrimination of test drug Incidental Cost

4009 Drug Cost - Not to Exceed 1 EA $500 $500

GRAND TOTAL

BASE YEAR OPTION YEAR I OPTION YEAR II OPTION YEAR III OPTION YEAR IV

GRAND TOTAL $

File details come from the government source that posted it.